XML 14 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed consolidated statements of operations and comprehensive loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating expenses    
Research and development $ 104 $ 10,508
General and administrative (Note 7) 2,555 4,309
Total operating expenses 2,659 14,817
Other income, net (Note 8) 451 194
Net loss $ (2,208) $ (14,623)
Net loss per common stock-basic and diluted (Note 9) $ (0.09) $ (0.62)
Basic and diluted weighted average number of common stock outstanding 23,537,368 23,480,757
Comprehensive loss:    
Net loss $ (2,208) $ (14,623)
Other comprehensive income - unrealized gain on available-for-sale securities   46
Comprehensive loss $ (2,208) $ (14,577)